Squamous Cell Carcinoma of Head and Neck research hub
3 indexed studies · 3 currently recruiting
- recruitingPHASE2
European Larynx Organ Preservation Study (ELOS) [MK-3475-C44]
This study looks at treating advanced throat cancer (larynx or hypopharynx) with chemotherapy and radiation, adding a new drug, Pembrolizumab (Keytruda®). It aims to see if this new treatment can help patients keep their larynx and live longer, healthier lives.
Germany - not yet recruitingPHASE2, PHASE3
DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
This study looks at two drugs called dabrafenib and trametinib for various cancers with a specific gene change (BRAF V600). These drugs are already approved for some cancers and researchers want to see if they can help people with other rare cancers or cancers with this same change.
United Kingdom - recruitingPHASE2, PHASE3
DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.
This study is for adults with specific cancers that have a change called BRAF V600. It's testing if two drugs, vemurafenib and cobimetinib, already used for a type of skin cancer, can help treat these other cancers. The goal is to find new treatments for patients.
United Kingdom